Raed Dweik, MD
- Respiratory Institute
- Pulmonary and Critical Care
- Cleveland Clinic
Pulmonary Hypertension is a rare and serious lung disorder. It occurs in individuals of all ages, races, and ethnic backgrounds although it is much more common in young adults and is approximately twice as common in women as in men. Symptoms of pulmonary hypertension do not usually occur until the condition has progressed. The first symptom of pulmonary hypertension is usually shortness of breath with everyday activities, such as climbing stairs. In more advanced stages of the disease, even minimal activity will produce some of the symptoms. Additional symptoms include irregular heart beat (palpitations or strong, throbbing sensation), racing pulse, passing out or dizziness, progressive shortness of breath during exercise or activity, and difficulty breathing at rest. Eventually, it may become difficult to carry out any activities as the disease worsens. Appropriate diagnosis and analysis of the problem is necessary before starting any treatment. Treatment varies per individual based on the different underlying causes but generally includes taking medications; making lifestyle and dietary changes; having surgery, if necessary; and seeing your doctor regularly.
Take this opportunity to learn more about Pulmonary Hypertension, including diagnosis and treatment, and have your questions answered by Dr. Raed Dweik at the Cleveland Clinic.
About the Speaker
Raed A. Dweik, M.D. is Professor of Medicine and Director of the Pulmonary Vascular Program in the Departments of Pulmonary and Critical Care Medicine in the Respiratory Institute at Cleveland Clinic. He is board certified in internal medicine, pulmonary disease, and critical care medicine. Dr. Dweik's clinical interests are in pulmonary hypertension, asthma, critical care, and chronic beryllium disease. He has a joint appointment in the department of Pathobiology in the Lerner Research Institute (LRI) and is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Dweik's research interests are in exhaled breath analysis and the role of nitric oxide in cardiopulmonary physiology and disease especially pulmonary hypertension and asthma. He served on several related national and international panels and committees including: the American Thoracic Society (ATS) Chronic Beryllium Disease Diagnosis and Management Committee, the ATS taskforce to Standardize measurement of Nitric Oxide (NO) in exhaled breath, and the Joint ATS-ERS taskforce on Exhaled Breath Condensate (EBC). He also chaired the ATS committee writing the guidelines for the use and interpretation of exhaled NO (FENO) in clinical practice and the ATS committee on pulmonary hypertension phenotypes.
To make an appointment with Dr. Dweik, or any of the other specialists in Cleveland Clinic’s Respiratory Institute, please call 216.445.5763 toll-free at 800.223.2273 (extension 55763) or visit us at clevelandclinic.org/pulmonaryhypertension for more information.
This Health Chat will open on
Sunday, September 14, 2014
to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.